FDA Approves New Hot Flash Treatment for Menopause

by Christopher Freeburn | October 4, 2013 9:33 am

prescription pills in bottles[1]Women who experience strong physical effects associated with menopause will have a new drug to treat the symptoms early next year[2].

The U.S. Food and Drug Administration has given the green light for Duavee, a drug made by Pfizer (PFE[3]) and Ligand Pharmaceuticals (LGND[4]), to hit the market. The treatment is designed to mitigate moderate-to-severe menopausal hot flashes in women who have not undergone a hysterectomy, Bloomberg notes.

Duavee, which will is expected to reach consumers in the first quarter of 2014, also protects bone density in post-menopausal women. Nausea, diarrhea, abdominal pain and muscle spasms are among the side effects attributed to the drug.

A number of other treatments already exist to combat the effects of hot flashes, including Evista from Eli Lilly (LLY[5]) and Brisdelle from Hisamitsu Pharmaceutical. Evista accounted for $1 billion in sales last year.

Shares of Pfizer dipped slightly in Friday morning trading, while Ligand Pharmaceutical rose modestly.

  1. [Image]: https://investorplace.com/wp-content/uploads/2011/07/11927463-prescription-medicine-spilling-from-open-bottles.jpg
  2. will have a new drug to treat the symptoms early next year: http://www.bloomberg.com/news/2013-10-03/pfizer-ligand-win-u-s-approval-for-hot-flash-therapy.html
  3. PFE: http://studio-5.financialcontent.com/investplace/quote?Symbol=PFE
  4. LGND: http://studio-5.financialcontent.com/investplace/quote?Symbol=LGND
  5. LLY: http://studio-5.financialcontent.com/investplace/quote?Symbol=LLY

Source URL: https://investorplace.com/2013/10/fda-approves-new-hot-flash-treatment-for-menopause/
Short URL: http://invstplc.com/1nyjojx